Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Promomed will continue to produce an analog of Ozempik

12/28/24 PRMD

Magnit shareholders did not approve dividends

12/28/24 MGNT

Sovcombank's nabsovet determined the price of share buyback from dissenters

12/28/24 SVCB

Binnopharm Group to enter the Iraqi market

12/28/24 AFKS

Shareholders of Diasoft approved dividends

12/28/24 DIAS

Shareholders of Astra approved dividends

12/28/24 ASTR

Moscow Exchange plans to launch futures on semiconductor and AI industry

12/27/24 MOEX

Alrosa expects diamond prices to rise

12/27/24 ALRS

T-Bank to open branches in China

12/27/24 T

Samolet has started construction of the first residential complex in Kazan

12/27/24 SMLT